Upvotes
5
Views
9
Score
58
Algorithm Analysis: Roylton
Roylton shows real substance: a named legal entity, an approved Canton validator node, and a clearly described royalty-tokenization product with a secondary-market concept. The main gaps are that the product is still in testnet, team/community/partnership details are absent, and documentation is thin beyond the homepage/description. With mainnet launch, client adoption, and more formal docs, it could score higher.
Last analyzed: Oct 11, 2026
Roylton on Canton
Tokenizes music, pharma and franchise royalty streams as Canton-native assets, with real-time distributions and a live secondary market
About Roylton
Roylton tokenises royalty streams as Canton-native assets, covering music catalogs, pharma licensing and franchise revenue. Holders are paid automatically the instant revenue lands, and a live secondary market lets anyone exit early or buy in at the current yield. Issuers raise non-dilutive capital against future revenue while keeping ownership and creative control, and holders face no lockups. Settlement is privacy-preserved, which matters because royalty terms are commercially sensitive, and the team chose Canton because most chains broadcast every contract term publicly. Roylton Labs Inc is also an approved Canton validator operator, approved on August 5, 2026 and onboarded on August 22, 2026, running the node roylton-mainnet-1. The product is in testnet.
Features
What the product does
Royalty streams tokenised as Canton-native assets
Royalty streams tokenised as Canton-native assets
Distributions settle the instant revenue lands
Distributions settle the instant revenue lands
Live secondary market to exit early or buy in at current yield
Live secondary market to exit early or buy in at current yield
Sell a slice of a royalty, keep the rest
Sell a slice of a royalty, keep the rest
Non-dilutive capital for creators and IP holders
Non-dilutive capital for creators and IP holders
No lockups for holders
No lockups for holders
rivacy-preserved on-chain settlement
rivacy-preserved on-chain settlement
Three verticals: music, pharma licensing and franchise revenue
Three verticals: music, pharma licensing and franchise revenue



